Company Profile

Grifols SA (NASDAQ: GRFS)
9:00 PM UTC, 11/21/24
Last: $8.54 Change: -0.06 %Change: -0.70% Volume: 632,310
Detailed Quote
Open: $ 8.44   Volume: 632,310
High: $ 8.59   Yield(%) 0.00
Low: $ 8.18   P/E Ratio (ttm): 91.10
Dividend ($): 0.36   Market Cap ($): 2.21B
EPS ($) 0.21   Shares Out: 257.44M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -2.60
% Price Change (last 13 weeks): 12.13
% Price Change (last 26 weeks): 19.61
% Price Change (last 52 weeks): -10.97
% Price Change (year to date): -25.61
Management Effectiveness
Return on Equity (%): 0.99
Return on Assets (%): 0.27
Return on Invested Capital (%): 2.82
Profitability
Gross Profit Margin (%): 35.24
Net Profit Margin (%): 0.90
Operating Profit Margin (%): 11.19
Price & Volume
50-day Moving Average: $8.86
200-day Moving Average: $7.76
Avg. Daily Vol. (last 50 days): 868,992
Avg. Daily Vol. (last 200 days): 1,567,701
52-wk high: $12.15
52-wk low: $5.30
Bid: $8.33
Ask: $8.40
Company Information
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
Grifols SA
Avinguda de la Generalitat, 152-158 Parc de Negocis Can Sant Joan Sant Cugat del Vallès
Barcelona CT 08174

Phone: 34.93.571.02.21
Fax: 34.93.571.02.67
http://www.grifols.com
Per Share Data
Earnings (1year) ($): 0.25
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): 91.10
Book Value ($): 25.06
Cash Flow ($): 2.11
Valuation Ratios
Price/Earnings (x): 91.10
Price/Sales (x): 1.10
Price/Book (x): 0.46
Price/Cash Flow (x): 34.86
Financial Strength
Quick Ratio (x): 1.29
Current Ratio (x): 2.79
LT Debt/Equity (x): 158.22
Total Debt/Equity (x): 173.63



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.